Welcome to LookChem.com Sign In|Join Free
  • or
Fagomine, an alkaloid derived from Fagopyrum esculentum, is a trisubstituted piperidine crystalline hydrochloride with a melting point of 176-177°C. It is an iminosugar known for its potential health benefits, particularly in reducing the risks of insulin resistance and becoming overweight.

53185-12-9

Post Buying Request

53185-12-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53185-12-9 Usage

Uses

Used in Pharmaceutical Applications:
Fagomine is used as a therapeutic agent for reducing the risks of insulin resistance and becoming overweight. It helps in lowering blood glucose levels and modulating bacterial adhesion, making it a promising candidate for the development of treatments for diabetes and related metabolic disorders.
Used in Nutritional Supplements:
Fagomine can be used as an ingredient in nutritional supplements aimed at promoting healthy blood glucose levels and supporting weight management. Its ability to modulate bacterial adhesion may also contribute to improved gut health and overall well-being.
Used in Research and Development:
Fagomine's unique structure and properties make it an interesting compound for further research and development in the fields of pharmaceuticals, nutrition, and biotechnology. Its potential applications in these areas could lead to the discovery of new treatments and products for various health conditions.

References

Koyanam Sakamura, Agr. Bioi. Chem., 38,1111 (1974)

Check Digit Verification of cas no

The CAS Registry Mumber 53185-12-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,1,8 and 5 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 53185-12:
(7*5)+(6*3)+(5*1)+(4*8)+(3*5)+(2*1)+(1*2)=109
109 % 10 = 9
So 53185-12-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO3/c8-3-4-6(10)5(9)1-2-7-4/h4-10H,1-3H2/t4-,5-,6-/m1/s1

53185-12-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3R,4R)-2-(hydroxymethyl)piperidine-3,4-diol

1.2 Other means of identification

Product number -
Other names 1,5-imino-1,2,5-trideoxy-D-arabino hexitol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53185-12-9 SDS

53185-12-9Synthetic route

6-[(allyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose

6-[(allyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With triethylsilane; palladium on activated charcoal; hydrogen In ethanol at 20℃;100%
(2R,3R,4R)-benzyl 3,4-bis(benzyloxy)-2-(hydroxymethyl)piperidine-1-carboxylate
1430587-89-5

(2R,3R,4R)-benzyl 3,4-bis(benzyloxy)-2-(hydroxymethyl)piperidine-1-carboxylate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogenchloride; palladium on activated charcoal; hydrogen In ethanol; water for 12h; Inert atmosphere;95%
(2R,3R,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)piperidine
366815-76-1

(2R,3R,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)piperidine

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen; acetic acid at 27℃; for 12h;87%
With hydrogenchloride; palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 2585.81 Torr; for 18h;82%
(4aR,8R,8aR)-tert-butyl hexahydro-8-hydroxy-2,2-dimethyl[1,3]dioxino[5,4-b]pyridine-5-carboxylate
768387-41-3

(4aR,8R,8aR)-tert-butyl hexahydro-8-hydroxy-2,2-dimethyl[1,3]dioxino[5,4-b]pyridine-5-carboxylate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Stage #1: (4aR,8R,8aR)-tert-butyl hexahydro-8-hydroxy-2,2-dimethyl[1,3]dioxino[5,4-b]pyridine-5-carboxylate With hydrogenchloride In methanol; water at 60℃; for 2h;
Stage #2: With DOWEX-50wX8 Further stages.;
83%
With hydrogenchloride In methanol; ethyl acetate for 2h;
(3S,4R)-6-[(benzyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose
121742-14-1

(3S,4R)-6-[(benzyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose

A

D-fagomine
53185-12-9

D-fagomine

B

(2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol

(2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol; water at 20℃; under 2585.81 Torr;A 83%
B n/a
(1S,2R,6R)-2-(tert-butyldiphenylsilanyloxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid tert-butyl ester
354153-41-6

(1S,2R,6R)-2-(tert-butyldiphenylsilanyloxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid tert-butyl ester

A

D-fagomine
53185-12-9

D-fagomine

B

(2R,3S,4S)-2-(hydroxymethyl)piperidine-3,4-diol

(2R,3S,4S)-2-(hydroxymethyl)piperidine-3,4-diol

Conditions
ConditionsYield
Stage #1: (1S,2R,6R)-2-(tert-butyldiphenylsilanyloxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid tert-butyl ester With potassium hydroxide In 1,4-dioxane
Stage #2: With hydrogenchloride In methanol at 60℃; for 1h;
A 17%
B 82%
With sulfuric acid In 1,4-dioxane; waterA 44%
B 33%
With sulfuric acid In 1,4-dioxane; water at 95℃; for 3h;A 44%
B 33%
(2R,3R,4R)-3-(tert-butyldimethylsilyloxy)-2-((tert-butyldimethylsilyloxy)methyl)piperidin-4-ol
1349697-04-6

(2R,3R,4R)-3-(tert-butyldimethylsilyloxy)-2-((tert-butyldimethylsilyloxy)methyl)piperidin-4-ol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogenchloride; water at 20℃; for 24h;82%
5,6-dideoxy-6(trifluoroacetamido)-D-threo-hexulose
115827-05-9

5,6-dideoxy-6(trifluoroacetamido)-D-threo-hexulose

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With 10 wt% Pd(OH)2 on carbon; hydrogen; potassium carbonate In water under 2585.81 Torr;81%
(2S,3R,4R)-1-benzyl-3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]piperidine
1129725-82-1

(2S,3R,4R)-1-benzyl-3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]piperidine

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 2585.81 Torr; for 24h;80%
(1R,2R,6S)-2-(tert-butyldiphenylsilanyloxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid tert-butyl ester
354153-40-5

(1R,2R,6S)-2-(tert-butyldiphenylsilanyloxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylic acid tert-butyl ester

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With sulfuric acid In 1,4-dioxane; water75%
With sulfuric acid In 1,4-dioxane; water at 95℃; for 3h;75%
4-O-benzyl-N-benzyloxycarbonyl-1,5-imino-1,2,5-trideoxy-D-arabino-hexitol
98260-69-6

4-O-benzyl-N-benzyloxycarbonyl-1,5-imino-1,2,5-trideoxy-D-arabino-hexitol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogen; palladium hydroxide - carbon In ethanol for 12h;74%
With hydrogen; palladium dihydroxide In ethanol
With hydrogen; acetic acid; palladium under 760 Torr; for 18h;
2-Desoxy-L-threo-5-hexulosonitril
143706-32-5

2-Desoxy-L-threo-5-hexulosonitril

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In water; acetic acid under 60004.8 Torr; for 0.266667h; Ambient temperature;70%
(3aR,4R,7aR)-methyl octahydro-1,1,3,3-tetramethyl-6-oxo-[1,2,5]oxadisilolo[3,4-c]pyridine-4-carboxylate
1333312-83-6

(3aR,4R,7aR)-methyl octahydro-1,1,3,3-tetramethyl-6-oxo-[1,2,5]oxadisilolo[3,4-c]pyridine-4-carboxylate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Stage #1: (3aR,4R,7aR)-methyl octahydro-1,1,3,3-tetramethyl-6-oxo-[1,2,5]oxadisilolo[3,4-c]pyridine-4-carboxylate With lithium aluminium tetrahydride In diethyl ether at 0℃; Reflux; Inert atmosphere;
Stage #2: With potassium hydrogenfluoride; dihydrogen peroxide In tetrahydrofuran; methanol at 60℃; for 15h; Fleming-Tamao oxidation; Inert atmosphere;
68%
1,2,5-trideoxy-4-O-(β-D-glucopyranosyl)-1,5-imino-D-arabinohexitol
104958-79-4

1,2,5-trideoxy-4-O-(β-D-glucopyranosyl)-1,5-imino-D-arabinohexitol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 2h;
(3S,4R)-6-[(benzyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose
121742-14-1

(3S,4R)-6-[(benzyloxycarbonyl)amino]-5,6-dideoxy-2-hexulose

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In methanol; water under 2585.7 Torr; for 24h; Yield given;
With hydrogen; diethylamine; palladium dihydroxide In methanol; water; N,N-dimethyl-formamide at 20℃; under 20686.5 Torr;
3-[(benzyloxycarbonyl)amino]propanal
65564-05-8

3-[(benzyloxycarbonyl)amino]propanal

FDP

FDP

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Zn2+-FDP aldolase further aldolase; Yield given. Multistep reaction;
(3S)-6-{[(benzyloxy)carbonyl]amino}-5,6-dideoxy-1-O-phosphonohex-2-ulose sodium salt

(3S)-6-{[(benzyloxy)carbonyl]amino}-5,6-dideoxy-1-O-phosphonohex-2-ulose sodium salt

A

D-fagomine
53185-12-9

D-fagomine

B

(2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol

(2S,3R,4S)-2-(hydroxymethyl)piperidine-3,4-diol

Conditions
ConditionsYield
Stage #1: (3S)-6-{[(benzyloxy)carbonyl]amino}-5,6-dideoxy-1-O-phosphonohex-2-ulose sodium salt With acid phosphatase EC 3.1.3.2 Acid hydrolysis;
Stage #2: With hydrogen; palladium on activated charcoal In methanol under 2585.81 Torr; for 24h; Further stages. Title compound not separated from byproducts.;
3,4-dibenzyloxy-1,5-imino-1,2,5-trideoxy-D-arabino hexitol
943135-43-1

3,4-dibenzyloxy-1,5-imino-1,2,5-trideoxy-D-arabino hexitol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In acetic acid at 20℃; for 48h;
(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxy-1-(tert-butyl-dimethylsilyloxy)pentane
943135-45-3

(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxy-1-(tert-butyl-dimethylsilyloxy)pentane

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: p-TsOH / methanol / 3 h / 20 °C
2.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
3.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
3.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
4.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
5.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
6.1: O3 / CH2Cl2; methanol / -78 °C
6.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
7.1: aq. HCl / methanol / 5 h / 70 °C
8.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxypentan-1-ol
943135-38-4

(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxypentan-1-ol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
2.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
2.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
3.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
4.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
5.1: O3 / CH2Cl2; methanol / -78 °C
5.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
6.1: aq. HCl / methanol / 5 h / 70 °C
7.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(2S,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxypentanal
943135-46-4

(2S,3R)-5-[N-(tert-butoxycarbonyl)amino]-2,3-dibenzyloxypentanal

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
1.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
2.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
3.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
4.1: O3 / CH2Cl2; methanol / -78 °C
4.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
5.1: aq. HCl / methanol / 5 h / 70 °C
6.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
ethyl (4R,5R)-7-[N-(tert-butoxycarbonyl)amino]-4,5-dibenzyloxy-2-heptenoate
943135-42-0

ethyl (4R,5R)-7-[N-(tert-butoxycarbonyl)amino]-4,5-dibenzyloxy-2-heptenoate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
2.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
3.1: O3 / CH2Cl2; methanol / -78 °C
3.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
4.1: aq. HCl / methanol / 5 h / 70 °C
5.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(4R,5R)-7-[N-(tert-butoxycarbonyl)amino]-4,5-dibenzyloxy-2-hepten-1-ol
943135-39-5

(4R,5R)-7-[N-(tert-butoxycarbonyl)amino]-4,5-dibenzyloxy-2-hepten-1-ol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
2.1: O3 / CH2Cl2; methanol / -78 °C
2.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
3.1: aq. HCl / methanol / 5 h / 70 °C
4.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(2R,3R,4R)-N-tert-butoxycarbonyl-3,4-dibenzyloxy-2-vinylpiperidine
943135-40-8

(2R,3R,4R)-N-tert-butoxycarbonyl-3,4-dibenzyloxy-2-vinylpiperidine

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: O3 / CH2Cl2; methanol / -78 °C
1.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
2.1: aq. HCl / methanol / 5 h / 70 °C
3.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(2R,3R,4R)-(N-tert-butoxycarbonyl-3,4-dibenzyloxy-2-piperidinyl)methanol
943135-41-9

(2R,3R,4R)-(N-tert-butoxycarbonyl-3,4-dibenzyloxy-2-piperidinyl)methanol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. HCl / methanol / 5 h / 70 °C
2: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(E)-tert-butyl (5-hydroxypent-3-en-1-yl)carbamate
333438-48-5

(E)-tert-butyl (5-hydroxypent-3-en-1-yl)carbamate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 89 percent / imidazole / dimethylformamide / 3 h / 20 °C
2.1: AD-mix-β; methanesulfonamide / 2-methyl-propan-2-ol; H2O / 20 h / 0 °C
3.1: NaH / tetrahydrofuran / 1.5 h / 0 °C
3.2: tetrabutylammonium iodide / tetrahydrofuran / 4 h / 20 °C
4.1: p-TsOH / methanol / 3 h / 20 °C
5.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
6.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
6.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
7.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
8.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
9.1: O3 / CH2Cl2; methanol / -78 °C
9.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
10.1: aq. HCl / methanol / 5 h / 70 °C
11.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
5-[N-(tert-butoxycarbonyl)amino]-1-(tert-butyl-dimethylsilyloxy)-2-pentene
943135-37-3

5-[N-(tert-butoxycarbonyl)amino]-1-(tert-butyl-dimethylsilyloxy)-2-pentene

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: AD-mix-β; methanesulfonamide / 2-methyl-propan-2-ol; H2O / 20 h / 0 °C
2.1: NaH / tetrahydrofuran / 1.5 h / 0 °C
2.2: tetrabutylammonium iodide / tetrahydrofuran / 4 h / 20 °C
3.1: p-TsOH / methanol / 3 h / 20 °C
4.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
5.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
5.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
6.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
7.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
8.1: O3 / CH2Cl2; methanol / -78 °C
8.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
9.1: aq. HCl / methanol / 5 h / 70 °C
10.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-1-(tert-butyl-dimethylsilyloxy)pentan-2,3-diol
943135-44-2

(2R,3R)-5-[N-(tert-butoxycarbonyl)amino]-1-(tert-butyl-dimethylsilyloxy)pentan-2,3-diol

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: NaH / tetrahydrofuran / 1.5 h / 0 °C
1.2: tetrabutylammonium iodide / tetrahydrofuran / 4 h / 20 °C
2.1: p-TsOH / methanol / 3 h / 20 °C
3.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
4.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
4.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
5.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
6.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
7.1: O3 / CH2Cl2; methanol / -78 °C
7.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
8.1: aq. HCl / methanol / 5 h / 70 °C
9.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
ethyl (E)-5-(tert-butoxycarbonylamino)pent-2-enoate
878003-30-6

ethyl (E)-5-(tert-butoxycarbonylamino)pent-2-enoate

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: 99 percent / DIBAL-H / tetrahydrofuran; hexane / 2 h / -78 °C
2.1: 89 percent / imidazole / dimethylformamide / 3 h / 20 °C
3.1: AD-mix-β; methanesulfonamide / 2-methyl-propan-2-ol; H2O / 20 h / 0 °C
4.1: NaH / tetrahydrofuran / 1.5 h / 0 °C
4.2: tetrabutylammonium iodide / tetrahydrofuran / 4 h / 20 °C
5.1: p-TsOH / methanol / 3 h / 20 °C
6.1: IBX / tetrahydrofuran; dimethylsulfoxide / 4 h / 20 °C
7.1: NaH / tetrahydrofuran / 0.17 h / 0 °C
7.2: 2.86 g / tetrahydrofuran / 0.5 h / Heating
8.1: DIBAL-H / tetrahydrofuran / 5 h / 20 °C
9.1: PdCl2(MeCN)2 / tetrahydrofuran / 3 h / 20 °C
10.1: O3 / CH2Cl2; methanol / -78 °C
10.2: NaBH4 / CH2Cl2; methanol / -78 - 20 °C
11.1: aq. HCl / methanol / 5 h / 70 °C
12.1: H2 / Pd/C / acetic acid / 48 h / 20 °C
View Scheme
(4aR,8aS)-2,2-dimethyl-4,4a,6,8a-tetrahydro[1,3]dioxino[5,4-b]pyridine-5-carboxylic acid tert-butyl ester
768387-38-8

(4aR,8aS)-2,2-dimethyl-4,4a,6,8a-tetrahydro[1,3]dioxino[5,4-b]pyridine-5-carboxylic acid tert-butyl ester

D-fagomine
53185-12-9

D-fagomine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 45 percent / Na2EDTA; CF3COCH3; NaHCO3 / Oxone / acetonitrile / 1.5 h / 0 °C
2.1: 78 percent / Super-Hydride / tetrahydrofuran / 3 h / 0 °C
3.1: HCl / methanol; H2O / 2 h / 60 °C
3.2: 83 percent / DOWEX-50wX8
View Scheme
Multi-step reaction with 3 steps
1: oxone(R); 1,1,1-trifluoro-2-propanone; edetate disodium; sodium hydrogencarbonate / acetonitrile / 1 h / 0 °C
2: lithium triethylborohydride / tetrahydrofuran / 0 °C
3: hydrogenchloride / methanol; ethyl acetate / 2 h
View Scheme
D-fagomine
53185-12-9

D-fagomine

butyl isothiocyanate
592-82-5

butyl isothiocyanate

N-(N'-butylthiocarbamoyl)-D-fagomine

N-(N'-butylthiocarbamoyl)-D-fagomine

Conditions
ConditionsYield
With pyridine; triethylamine at 20℃; for 18h;93%
C19H35NO2S

C19H35NO2S

D-fagomine
53185-12-9

D-fagomine

N-[N'-(16-acetoxyhexadecyl)thiocarbamoyl]-D-fagomine

N-[N'-(16-acetoxyhexadecyl)thiocarbamoyl]-D-fagomine

Conditions
ConditionsYield
With pyridine; triethylamine at 20℃; for 18h;88%
1-heptyl isothiocyanate
4426-83-9

1-heptyl isothiocyanate

D-fagomine
53185-12-9

D-fagomine

N-(N'-octythiocarbamoyl)-D-fagomine

N-(N'-octythiocarbamoyl)-D-fagomine

Conditions
ConditionsYield
With pyridine; triethylamine at 20℃; for 18h;80%
D-fagomine
53185-12-9

D-fagomine

(2R,3R,4R)-N-benzyloxycarbonyl-3,4-dihydroxy-2-((phenylamino)methyl)pyrrolidine
129492-51-9, 129492-77-9

(2R,3R,4R)-N-benzyloxycarbonyl-3,4-dihydroxy-2-((phenylamino)methyl)pyrrolidine

(2R,3R,4R)-N-benzyloxycarbonyl-2-(((2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)piperidin-1-yl)methyl)-3,4-dihydroxypyrrolidine
1427173-81-6

(2R,3R,4R)-N-benzyloxycarbonyl-2-(((2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)piperidin-1-yl)methyl)-3,4-dihydroxypyrrolidine

Conditions
ConditionsYield
With acetic acid In methanol at 20℃; for 2h;52%
D-fagomine
53185-12-9

D-fagomine

butyraldehyde
123-72-8

butyraldehyde

(2R,3R,4R)-1-butyl-2-(hydroxymethyl)piperidine-3,4-diol

(2R,3R,4R)-1-butyl-2-(hydroxymethyl)piperidine-3,4-diol

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol; water at 20℃; under 2585.81 Torr;47%
benzaldehyde dimethyl acetal
1125-88-8

benzaldehyde dimethyl acetal

D-fagomine
53185-12-9

D-fagomine

benzyl chloroformate
501-53-1

benzyl chloroformate

4,6-O-benzylidene-N-(benzyloxycarbonyl)fagomine

4,6-O-benzylidene-N-(benzyloxycarbonyl)fagomine

Conditions
ConditionsYield
With sodium hydrogencarbonate; toluene-4-sulfonic acid 1.) toluene, water, 0 deg C to 20 deg C, 4 h, 2.) DMF, 60 deg C, 1 h; Yield given. Multistep reaction;

53185-12-9Relevant academic research and scientific papers

Concise and highly stereoselective syntheses of D-fagomine and 2-epi-fagomine

Kallam, Srinivasa Reddy,Datrika, Rajender,Khobare, Sandip R.,Gajare, Vikas S.,Rajana, Nagaraju,Mohan, H. Rama,Babu, J. Moses,Siddaiah,Pratap

, p. 1351 - 1353 (2018/03/23)

Highly stereoselective total syntheses of polyhydroxylated piperidines D-fagomine and 2-epi-fagomine have been developed starting from 3,4,6-tri-O-benzyl-D-glucal which is a derivative of D-Glucose. Key steps in the synthesis of these azasugars involved N-Boc-protected amine preparation from oxime followed by stereo specific iodination of alcohol and cascade cyclization triggered by N-Boc deprotection.

A PROCESS FOR SYNTHESIS OF PIPERIDINE ALKALOIDS

-

, (2015/11/27)

The present invention discloses a process for synthesis of piperidine alkaloids selected from fagomine, 4-epi-fagomine and nojirimycin from tri-O-benzyl-D-glucal or tri-O-benzyl-D-galactal.

Transforming flask reaction into cell-based synthesis: Production of polyhydroxylated molecules via engineered Escherichia coli

Wei, Mohui,Li, Zijie,Li, Tiehai,Wu, Baolin,Liu, Yunpeng,Qu, Jingyao,Li, Xu,Li, Lei,Cai, Li,Wang, Peng George

, p. 4060 - 4065 (2015/11/11)

Dihydroxyacetone phosphate (DHAP)-dependent aldolases have been intensively studied and widely used in the synthesis of carbohydrates and complex polyhydroxylated molecules. However, strict specificity toward donor substrate DHAP greatly hampers their synthetic utility. Here, we transformed DHAP-dependent aldolases-mediated by in vitro reactions into bioengineered Escherichia coli (E. coli). Such flask-to-cell transformation addressed several key issues plaguing in vitro enzymatic synthesis: (1) it solves the problem of DHAP availability by in vivo-hijacking DHAP from the glycolysis pathway of the bacterial system, (2) it circumvents purification of recombinant aldolases and phosphatase, and (3) it dephosphorylates the resultant aldol adducts in vivo, thus eliminating the additional step for phosphate removal and achieving in vivo phosphate recycling. The engineered E. coli strains tolerate a wide variety of aldehydes as acceptor and provide a set of biologically relevant polyhydroxylated molecules in gram scale.

Applications and limitations of the I2-mediated carbamate annulation for the synthesis of piperidines: Five-versus six-membered ring formation

Corkran, Hilary M.,Munneke, Stefan,Dangerfield, Emma M.,Stocker, Bridget L.,Timmer, Mattie S. M.

, p. 9791 - 9802 (2013/10/22)

A protecting-group-free synthetic strategy for the synthesis of piperidines has been explored. Key in the synthesis is an I2-mediated carbamate annulation, which allows for the cyclization of hydroxy-substituted alkenylamines into piperidines, pyrrolidines, and furans. In this work, four chiral scaffolds were compared and contrasted, and it was observed that with both d-galactose and 2-deoxy-d-galactose as starting materials, the transformations into the piperidines 1-deoxygalactonorjirimycin (DGJ) and 4-epi-fagomine, respectively, could be achieved in few steps and good overall yields. When d-glucose was used as a starting material, only the furan product was formed, whereas the use of 2-deoxy-d-glucose resulted in reduced chemo- and stereoselectivity and the formation of four products. A mechanistic explanation for the formation of each annulation product could be provided, which has improved our understanding of the scope and limitations of the carbamate annulation for piperidine synthesis.

Total synthesis of d-fagomine and 6-deoxyfagomine

Min, Im Sook,Kim, Seung In,Hong, Seungmin,Kim, In Su,Jung, Young Hoon

, p. 3901 - 3906 (2013/06/27)

Total synthesis of d-fagomine and 6-deoxyfagomine from readily available d-lyxose is described. The key steps included regioselective and diastereoselective amination, hydroboration-oxidation, and Appel reaction. The reaction of 3,4-anti-tribenzyl ether with chlorosulfonyl isocyanate in toluene at 0 °C afforded 3,4-anti-amino alcohol, an essential compound for the preparation of d-fagomine and 6-deoxyfagomine, with a high diastereoselectivity (dr=26:1) in 74% yield. The origin of diastereoselectivity can be explained by the neighboring group effect, which leads to retention of the stereochemistry.

Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors

Van Den Berg, Richard J. B. H. N.,Wennekes, Tom,Ghisaidoobe, Amar,Donker-Koopman, Wilma E.,Strijland, Anneke,Boot, Rolf G.,Van Der Marel, Gijsbert A.,Aerts, Johannes M. F. G.,Overkleeft, Herman S.

supporting information; experimental part, p. 519 - 522 (2011/09/15)

Glucosylceramide synthase (GCS) is an approved drug target for the treatment of Gaucher disease and is considered as a valid target for combating other human pathologies, including type 2 diabetes. The clinical drug N-butyldeoxynojirimycin (Zavesca) is thought to inhibit through mimicry of its substrate, ceramide. In this work we demonstrate that, in contrast to what is proposed in this model, the C2-hydroxyl of the deoxynojirimycin core is important for GCS inhibition. Here we show that C6-OH appears of less important, which may set guidelines for the development of GCS inhibitors that have less affinity (in comparison with Zavesca) for other glycoprocessing enzymes, in particular those hydrolases that act on glucosylceramide.

Efficient and stereoselective syntheses of DAB-1 and D-fagomine via chiral 1,3-oxazine

Kim, Ji-Yeon,Mu, Yu,Jin, Xiangdan,Park, Seok-Hwi,Pham, Van-Thoai,Song, Dong-Keun,Lee, Kee-Young,Ham, Won-Hun

, p. 9426 - 9432 (2011/12/14)

The concise, stereocontrolled syntheses of DAB-1 and d-fagomine were achieved utilizing chiral oxazine. The key features in these strategies are the stereoselective intramolecular oxazine formation catalyzed by palladium(0), and pyrrolidine and piperidine formation by catalytic hydrogenation of oxazine.

Synthesis of non-natural carbohydrates from glycerol and aldehydes in a one-pot four-enzyme cascade reaction

Babich, Lara,Van Hemert, Lieke J. C.,Bury, Aleksandra,Hartog, Aloysius F.,Falcicchio, Pierpaolo,Van Der Oost, John,Van Herk, Teunie,Wever, Ron,Rutjes, Floris P. J. T.

experimental part, p. 2895 - 2900 (2011/12/05)

A simple procedure has been developed for the synthesis of enantio- and diastereomerically pure carbohydrate analogues from glycerol and a variety of aldehydes in one pot using a four-enzyme cascade reaction. As a proof of concept of the usefulness of this enzymatic catalytic cascade the naturally occurring azasugar d-fagomine was synthesized. This work highlights the potential value of using enzymes in cascade reactions to selectively form complex products that by previous traditional organic chemistry could only be obtained via repeated isolation and purification of intermediates.

Silicon-mediated asymmetric synthesis of fagomine and 3,4-di-epi-fagomine

Kundu, Pintu K.,Ghosh, Sunil K.

, p. 1090 - 1096 (2011/10/04)

The synthesis of d-fagomine and its stereoisomer, d-3,4-di-epi-fagomine has been achieved from C2-symmetric 3,4-bis-silyl substituted adipic acid di-oxazolidin-2-one derivatives via stereocontrolled azidation and silicon to hydroxyl conversion as the key steps. The Evans oxazolidin-2-one controlled the stereochemical outcome of the azidation which supersedes the directing effects of the silyl substituent.

Efficient and stereodivergent syntheses of D- and L-fagomines and their analogues

Kumari, Nitee,Reddy, B. Gopal,Vankar, Yashwant D.

experimental part, p. 160 - 169 (2009/08/09)

The syntheses of D- and L-fagomines 1, 4, 5 and 6 and their isomers from starting D-glycals have been achieved. The syntheses involve elaboration of common amino alcohol precursors obtained from 2-deoxy-1-amino sugar derivatives. The key steps in the synt

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 53185-12-9